FDA to Discuss Using XML for Electronic Investigational New Drug Applications

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to gather feedback on using extensible markup language (XML) to create a cumulative table of contents for investigational new drug applications (INDs) that will be submitted electronically to the FDA's Center for Biologics Evaluation and Research (CBER) or the Center for Drug Evaluation and Research (CDER).